|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.97 USD | -0.69% |
|
+1.22% | +5.44% |
| 07-16 | IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says | MT |
| 07-16 | Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47 | MT |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 11 | ||||||||
| 17 | ||||||||
| 19 | ||||||||
| 4 | ||||||||
| 7 | ||||||||
| 12 | ||||||||
| 2 | ||||||||
| 8 | ||||||||
| 9 | ||||||||
| - | - | - | - | |||||
| 3 | ||||||||
| - | - | |||||||
| 5 | ||||||||
| 12 | ||||||||
| - | - | |||||||
| 2 | ||||||||
| Average | 9 | |||||||
| Weighted average by Cap. | 12 |
- Stock Market
- Stocks
- IMAX Stock
- Sector IMAX Corporation
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
















